IP Library Assignment 036413/0122
Patent Assignment
Reel/Frame 036413/0122

Assignment of Assignor's Interest

Recorded: 2015-08-25 Pages: 4
Assignor
LEVETAN, CLARESA
Executed: 2014-03-26
Assignee
PERLE BIOSCIENCE, INC.
2250 CHRYSLER TERRACE, ATLANTA, GEORGIA, 30345
Covered Properties (11)
Mircocavity Plasma Panel Radiation Detectors
Application: 61/852,346 →
Generation of New Pancreatic Beta Cells
Patent: 8,911,776 →
Application: 13/662,209 →
Publication: US 2014/0120154
Generation of New Pancreatic Beta Cells
Application: 13/662,232 →
Publication: US 2014/0120560
Generation of New Pancreatic Beta Cells
Patent: 9,511,110 →
Application: 13/662,245 →
Publication: US 2014/0120097
Generation of New Pancreatic Beta Cells
Patent: 9,133,440 →
Application: 13/662,253 →
Publication: US 2014/0120064
Insulin Independence Among Patients with Diabetes Utilzing a Proton-Pump Inhibitor in Combination with an Immune Tolerance Agent
Application: 61/749,197 →
Insulin Independence Among Patients with Diabetes Utilizing a Ppi in Combination with an Immune Tolerance Agent
Application: 13/768,441 →
Publication: US 2014/0235552
Insulin Independence Among Patients with Diabetes Utilizing a Ppi in Combination with an Immune Tolerance Agent
Patent: 8,808,689 →
Application: 13/768,472 →
Publication: US 2014/0234264
Insulin Independence Among Patients with Diabetes Utilizing a Ppi in Combination with an Immune Tolerance Agent
Application: 13/768,542 →
Publication: US 2014/0234405
Generation of New Pancreatic Beta Cells
Insulin Independence Among Patients with Diabetes Utilizing a Ppi in Combination with an Immune Tolerance Agent
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 9, 2021
From: PERLE BIOSCIENCE, INC.
To: LEVETAN, CLARESA
Reel/Frame 055883/0062 →